Fingolimod for Irradiation-Induced Neurodegeneration

BackgroundCranial irradiation is a common therapy for the treatment of brain tumors, but unfortunately patients suffer from side effects, particularly cognitive impairment, caused by neurodegenerative and neuroinflammatory mechanisms. Finding a therapeutic agent protecting hippocampal neurons would...

Full description

Bibliographic Details
Main Authors: Judith Metzdorf, Zaynab Hobloss, Sibylle Schlevogt, Ilya Ayzenberg, Sarah Stahlke, Xiomara Pedreiturria, Steffen Haupeltshofer, Ralf Gold, Lars Tönges, Ingo Kleiter
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2019.00699/full
id doaj-1ff3b6d43f3e49c5b4b89b722eaaa9a6
record_format Article
spelling doaj-1ff3b6d43f3e49c5b4b89b722eaaa9a62020-11-25T01:54:36ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2019-07-011310.3389/fnins.2019.00699451355Fingolimod for Irradiation-Induced NeurodegenerationJudith Metzdorf0Zaynab Hobloss1Sibylle Schlevogt2Ilya Ayzenberg3Ilya Ayzenberg4Sarah Stahlke5Xiomara Pedreiturria6Steffen Haupeltshofer7Ralf Gold8Lars Tönges9Ingo Kleiter10Ingo Kleiter11Department of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, I.M. Sechenov First Moscow State Medical University, Moscow, RussiaDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyDepartment of Neurology, St. Josef-Hospital, Ruhr-University, Bochum, GermanyMarianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke, Berg, GermanyBackgroundCranial irradiation is a common therapy for the treatment of brain tumors, but unfortunately patients suffer from side effects, particularly cognitive impairment, caused by neurodegenerative and neuroinflammatory mechanisms. Finding a therapeutic agent protecting hippocampal neurons would be beneficial. Fingolimod (FTY720), a sphingosine-1-phosphate receptor modulator approved for multiple sclerosis, is an immunosuppressant and known to enhance proliferation and differentiation of neuronal precursor cells (NPCs).ObjectivesTo investigate whether pre-treatment with FTY720 protects NPCs in vitro and in vivo from irradiation-induced damage.MethodsNeuronal precursor cells were isolated from E13 C57BL/6 wildtype mice, treated at day 0 of differentiation with FTY720 and irradiated on day 6 with 1 Gy. NPCs were analyzed for markers of cell death (PI, caspase-3), proliferation (Ki67), and differentiation (DCX, βIII-tubulin). Adult C57BL/6 wildtype mice were treated with FTY720 (1 mg/kg) and received a single dose of 6 Gy cranial irradiation at day 7. Using immunohistochemistry, we analyzed DCX and BrdU as markers of neurogenesis and Iba1, GFAP, and CD3 to visualize inflammation in the dentate gyrus (DG) and the subventricular zone (SVZ). B6(Cg)-Tyrc-2J/J DCX-luc reporter mice were used for bioluminescence imaging to evaluate the effect of FTY720 on neurogenesis in the DG and the spinal cord of naïve mice.ResultsFTY720 protected NPCs against irradiation induced cell death in vitro. Treatment with FTY720 dose-dependently reduced the number of PI+ cells 24 and 96 h after irradiation without effecting proliferation or neuronal differentiation. In vivo treatment resulted in a significant survival of DCX+ neurons in the DG and the SVZ 4 weeks after irradiation as well as a slight increase of proliferating cells. FTY720 inhibited microglia activation 24 h after X-ray exposure in the DG, while astrocyte activation was unaffected and no lymphocyte infiltrations were found. In naïve mice, FTY720 treatment for 4 weeks had no effect on neurogenesis.ConclusionFTY720 treatment of NPCs prior to X-ray exposure and of mice prior to cranial irradiation is neuroprotective. No effects on neurogenesis were found.https://www.frontiersin.org/article/10.3389/fnins.2019.00699/fullfingolimodneuroprotectionX-rayradiationneurogenesisneuronal precursor cells
collection DOAJ
language English
format Article
sources DOAJ
author Judith Metzdorf
Zaynab Hobloss
Sibylle Schlevogt
Ilya Ayzenberg
Ilya Ayzenberg
Sarah Stahlke
Xiomara Pedreiturria
Steffen Haupeltshofer
Ralf Gold
Lars Tönges
Ingo Kleiter
Ingo Kleiter
spellingShingle Judith Metzdorf
Zaynab Hobloss
Sibylle Schlevogt
Ilya Ayzenberg
Ilya Ayzenberg
Sarah Stahlke
Xiomara Pedreiturria
Steffen Haupeltshofer
Ralf Gold
Lars Tönges
Ingo Kleiter
Ingo Kleiter
Fingolimod for Irradiation-Induced Neurodegeneration
Frontiers in Neuroscience
fingolimod
neuroprotection
X-ray
radiation
neurogenesis
neuronal precursor cells
author_facet Judith Metzdorf
Zaynab Hobloss
Sibylle Schlevogt
Ilya Ayzenberg
Ilya Ayzenberg
Sarah Stahlke
Xiomara Pedreiturria
Steffen Haupeltshofer
Ralf Gold
Lars Tönges
Ingo Kleiter
Ingo Kleiter
author_sort Judith Metzdorf
title Fingolimod for Irradiation-Induced Neurodegeneration
title_short Fingolimod for Irradiation-Induced Neurodegeneration
title_full Fingolimod for Irradiation-Induced Neurodegeneration
title_fullStr Fingolimod for Irradiation-Induced Neurodegeneration
title_full_unstemmed Fingolimod for Irradiation-Induced Neurodegeneration
title_sort fingolimod for irradiation-induced neurodegeneration
publisher Frontiers Media S.A.
series Frontiers in Neuroscience
issn 1662-453X
publishDate 2019-07-01
description BackgroundCranial irradiation is a common therapy for the treatment of brain tumors, but unfortunately patients suffer from side effects, particularly cognitive impairment, caused by neurodegenerative and neuroinflammatory mechanisms. Finding a therapeutic agent protecting hippocampal neurons would be beneficial. Fingolimod (FTY720), a sphingosine-1-phosphate receptor modulator approved for multiple sclerosis, is an immunosuppressant and known to enhance proliferation and differentiation of neuronal precursor cells (NPCs).ObjectivesTo investigate whether pre-treatment with FTY720 protects NPCs in vitro and in vivo from irradiation-induced damage.MethodsNeuronal precursor cells were isolated from E13 C57BL/6 wildtype mice, treated at day 0 of differentiation with FTY720 and irradiated on day 6 with 1 Gy. NPCs were analyzed for markers of cell death (PI, caspase-3), proliferation (Ki67), and differentiation (DCX, βIII-tubulin). Adult C57BL/6 wildtype mice were treated with FTY720 (1 mg/kg) and received a single dose of 6 Gy cranial irradiation at day 7. Using immunohistochemistry, we analyzed DCX and BrdU as markers of neurogenesis and Iba1, GFAP, and CD3 to visualize inflammation in the dentate gyrus (DG) and the subventricular zone (SVZ). B6(Cg)-Tyrc-2J/J DCX-luc reporter mice were used for bioluminescence imaging to evaluate the effect of FTY720 on neurogenesis in the DG and the spinal cord of naïve mice.ResultsFTY720 protected NPCs against irradiation induced cell death in vitro. Treatment with FTY720 dose-dependently reduced the number of PI+ cells 24 and 96 h after irradiation without effecting proliferation or neuronal differentiation. In vivo treatment resulted in a significant survival of DCX+ neurons in the DG and the SVZ 4 weeks after irradiation as well as a slight increase of proliferating cells. FTY720 inhibited microglia activation 24 h after X-ray exposure in the DG, while astrocyte activation was unaffected and no lymphocyte infiltrations were found. In naïve mice, FTY720 treatment for 4 weeks had no effect on neurogenesis.ConclusionFTY720 treatment of NPCs prior to X-ray exposure and of mice prior to cranial irradiation is neuroprotective. No effects on neurogenesis were found.
topic fingolimod
neuroprotection
X-ray
radiation
neurogenesis
neuronal precursor cells
url https://www.frontiersin.org/article/10.3389/fnins.2019.00699/full
work_keys_str_mv AT judithmetzdorf fingolimodforirradiationinducedneurodegeneration
AT zaynabhobloss fingolimodforirradiationinducedneurodegeneration
AT sibylleschlevogt fingolimodforirradiationinducedneurodegeneration
AT ilyaayzenberg fingolimodforirradiationinducedneurodegeneration
AT ilyaayzenberg fingolimodforirradiationinducedneurodegeneration
AT sarahstahlke fingolimodforirradiationinducedneurodegeneration
AT xiomarapedreiturria fingolimodforirradiationinducedneurodegeneration
AT steffenhaupeltshofer fingolimodforirradiationinducedneurodegeneration
AT ralfgold fingolimodforirradiationinducedneurodegeneration
AT larstonges fingolimodforirradiationinducedneurodegeneration
AT ingokleiter fingolimodforirradiationinducedneurodegeneration
AT ingokleiter fingolimodforirradiationinducedneurodegeneration
_version_ 1724986333223452672